Nuvation Bio Inc. — Investor Relations & Filings
Nuvation Bio Inc. is a biopharmaceutical company dedicated to developing and commercializing novel therapies for oncology. The company focuses on addressing significant unmet needs in cancer treatment, particularly for difficult-to-treat malignancies where conventional therapies have limited efficacy. Its strategy involves creating a pipeline of differentiated therapeutic candidates that target critical pathways essential for cancer cell growth. Nuvation Bio aims to overcome drug resistance, improve outcomes over current standards of care, and reduce side effects to preserve patient quality of life. The company's portfolio includes Ibtrozi, an approved oral drug for the treatment of ROS1-positive non-small cell lung cancer (NSCLC), alongside other clinical-stage candidates.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| ARS - Nuvation Bio Inc. (0001811063) (Filer) | 2026-04-10 | English | |
| DEF 14A - Nuvation Bio Inc. (0001811063) (Filer) | 2026-04-10 | English | |
| 4 - NUVATION BIO INC. (0001811063) (Filer) | 2026-03-04 | English | |
| 4 - NUVATION BIO INC. (0001811063) (Filer) | 2026-03-04 | English | |
| 4 - NUVATION BIO INC. (0001811063) (Filer) | 2026-03-04 | English | |
| 4 - NUVATION BIO INC. (0001811063) (Filer) | 2026-03-04 | English |
Browse filings by year
7 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AC Immune SA
Biopharmaceutical firm developing precision medicine for ne…
|
ACIU | CH | Manufacturing |
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
Nuvation Bio Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32154/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32154 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32154 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32154 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32154}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Nuvation Bio Inc. (id: 32154)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.